× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|Evidence breast cancer

Living evidence synthesis
about last generation of breast cancer treatments

Member of the meta|Evidence galaxy

Pathology browse pathologies  

Latest studies

TORCHLIGHT PDL 1 positive population, 2024

mBC - Triple negative (TNBC) - 1st Line (L1)

nab-paclitaxel

TORCHLIGHT PDL 1 positive population, 2024

mBC - Triple negative (TNBC) - 1st Line (L1)

toripalimab

FUTURE-SUPER, 2024

mBC - Triple negative (TNBC) - 1st Line (L1)

camrelizumab alone

FUTURE-SUPER, 2024

mBC - Triple negative (TNBC) - 1st Line (L1)

nab-paclitaxel

Treatments browse treatments

121
treatments 		  121
studies 		  232
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons